RESOLVE MATRIX Trademark

Trademark Overview

On Wednesday, November 30, 2022, a trademark application was filed for RESOLVE MATRIX with the United States Patent and Trademark Office. The USPTO has given the RESOLVE MATRIX trademark a serial number of 97698534. The federal status of this trademark filing is REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED as of Tuesday, November 19, 2024. This trademark is owned by Parametrics Medical, LLC. The RESOLVE MATRIX trademark is filed in the Pharmaceutical Products category with the following description:

Acellular, resorbable porcine mesothelium-derived matrix intended for the management of topical wounds

General Information

Serial Number97698534
Word MarkRESOLVE MATRIX
Filing DateWednesday, November 30, 2022
Status654 - REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED
Status DateTuesday, November 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesAcellular, resorbable porcine mesothelium-derived matrix intended for the management of topical wounds
NOT AVAILABLE"MATRIX"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, December 24, 2022
Primary Code005
First Use Anywhere DateWednesday, November 30, 2022
First Use In Commerce DateWednesday, November 30, 2022

Trademark Owner History

Party NameParametrics Medical, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLeander, TX 78641

Trademark Events

Event DateEvent Description
Saturday, December 24, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, December 3, 2022NEW APPLICATION ENTERED
Friday, September 8, 2023ASSIGNED TO EXAMINER
Monday, September 11, 2023NON-FINAL ACTION WRITTEN
Monday, September 11, 2023NON-FINAL ACTION E-MAILED
Monday, September 11, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 11, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 11, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 11, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 26, 2023SUSPENSION LETTER WRITTEN
Tuesday, September 26, 2023LETTER OF SUSPENSION E-MAILED
Tuesday, September 26, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, November 19, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, March 27, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

Related Keywords

matrix resolve intended management topical wounds derived resorbable porcine mesothelium acellular